Company
IndiaPublic company, NYSE: RDYDr. Reddy’s Laboratories Limited (NYSE: RDY), FTO-11, India – FDA Inspections
Inspection records and compliance data for Dr. Reddy’s Laboratories Limited in FTO-11, Survey No 30. 1 FDA inspection on record, 1 Form 483, last inspected July 18, 2025. Publicly traded as NYSE: RDY.
Company Profile
This profile covers Dr. Reddy’s Laboratories Limited based in FTO-11, Survey No 30, India.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 1
- Warning letters
- 0
Inspected July 18, 2025.
Most cited issue areas
- Equipment Design, Size and Location1 inspection
- In-process materials specifications testing1 inspection
- Investigations of discrepancies, failures1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 18, 2025 | VAI | Human Drugs · Drug Quality Assurance | 1277412 |
FDA documents
Form 483s (2)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Dr. Reddy’s Laboratories Limited
Stock ticker
RDY
Exchange
NYSE
Share price
$14.73
Market cap
$12.3B
Price as of
November 13, 2026
FEI Number
3012414462
Address
Formulations Technical Operations, FTO-11, Survey No 30, India
Country
India
ID: 19f1fec5-d1fb-47f3-92bb-7e3e0f0db5d6